Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients
Document Type: Research Article
Affiliations: 1: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China 2: Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China 3: Department of Respiratory Medicine, West China Hospital, Chengdu, Sichuan, P.R. China 4: Department of Thoracic Surgery, Shenzhen People’s Hospital, Second Clinical Medical College of Jinan University, Shenzhen, Guangdong, P.R. China 5: State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, P.R. China 6: Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, P.R. China 7: Burning Rock Biotech, Guangzhou, Guangdong, P.R. China
Publication date: May 7, 2019
This article was made available online on August 21, 2018 as a Fast Track article with title: "Clinical characteristics and molecular patterns of RET-rearranged lung cancer in Chinese patients".
Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.
From Volume 23, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics is Open Access under the terms of the Creative Commons CC BY-NC-ND license.